Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance
- PMID:16398565
- DOI: 10.2165/00003495-200666010-00001
Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance
Abstract
Evolving antimicrobial resistance is of global concern. The impact of decreased susceptibility to current antibacterials coupled with the decline in the marketing of new agents with novel mechanisms of action places a tremendous burden on clinicians to appropriately use available agents. Optimising antibacterial dose administration through the use of pharmacodynamic principles can aid clinicians in accomplishing this task more effectively. Methods to achieve this include: continuous or prolonged infusion, or the use of smaller doses administered more frequently for the time-dependent beta-lactam agents; or higher, less frequent dose administration of the concentration-dependent aminoglycosides and fluoroquinolones. Pharmacodynamic breakpoints, which are predictive of clinical and/or microbiological success in the treatment of infection, have been determined for many classes of antibacterials, including the fluoroquinolones, aminoglycosides and beta-lactams. Although surpassing these values may predict efficacy, it may not prevent the development of resistance. Recent studies seek to determine the pharmacodynamic breakpoints that prevent the development of resistance. Numerous studies to this point have determined these values in fluoroquinolones in both Gram-positive and Gram-negative bacteria. However, among the other antibacterial classes, there is a lack of sufficient data. Additionally, a new term, the mutant prevention concentration, has been based on the concentrations above which resistance is unlikely to occur. Future work is needed to fully characterise these target concentrations that prevent resistance.
Similar articles
- [Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].Mazzei T, Novelli A, Arrigucci S.Mazzei T, et al.Infez Med. 2009 Sep;17 Suppl 4:37-57.Infez Med. 2009.PMID:20428019Review.Italian.
- An update on the management of urinary tract infections in the era of antimicrobial resistance.Bader MS, Loeb M, Brooks AA.Bader MS, et al.Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.Postgrad Med. 2017.PMID:27712137Review.
- Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.Rice LB.Rice LB.Mayo Clin Proc. 2012 Feb;87(2):198-208. doi: 10.1016/j.mayocp.2011.12.003.Mayo Clin Proc. 2012.PMID:22305032Free PMC article.Review.
- Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.Roberts JA, Lipman J.Roberts JA, et al.Clin Pharmacokinet. 2006;45(8):755-73. doi: 10.2165/00003088-200645080-00001.Clin Pharmacokinet. 2006.PMID:16884316Review.
- Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.Furtado GH, Cardinal L, Macedo RS, Silva JO, Medeiros EA, Kuti JL, Nicolau DP.Furtado GH, et al.Rev Soc Bras Med Trop. 2015 Sep-Oct;48(5):539-45. doi: 10.1590/0037-8682-0122-2015.Rev Soc Bras Med Trop. 2015.PMID:26516962
Cited by
- Surgical site infection in pediatric spinal fusion surgery revisited: outcome and risk factors after preventive bundle implementation.Maisat W, Yuki K.Maisat W, et al.Perioper Care Oper Room Manag. 2023 Mar;30:100308. doi: 10.1016/j.pcorm.2023.100308. Epub 2023 Feb 1.Perioper Care Oper Room Manag. 2023.PMID:36817803Free PMC article.
- Optimized antimicrobial dosing strategies: a survey of pediatric hospitals.Knoderer CA, Nichols KR, Cox EG.Knoderer CA, et al.Paediatr Drugs. 2014 Dec;16(6):523-9. doi: 10.1007/s40272-014-0093-1.Paediatr Drugs. 2014.PMID:25315265
- In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.Elkhatib W, Noreddin A.Elkhatib W, et al.Antibiotics (Basel). 2014 Feb 17;3(1):64-84. doi: 10.3390/antibiotics3010064.Antibiotics (Basel). 2014.PMID:27025734Free PMC article.
- Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.Noreddin AM, Haynes V.Noreddin AM, et al.Drugs Aging. 2007;24(4):275-92. doi: 10.2165/00002512-200724040-00002.Drugs Aging. 2007.PMID:17432923Review.
- The "Torment" of Surgical Antibiotic Prophylaxis among Surgeons.Sartelli M, Coccolini F, Carrieri A, Labricciosa FM, Cicuttin E, Catena F.Sartelli M, et al.Antibiotics (Basel). 2021 Nov 6;10(11):1357. doi: 10.3390/antibiotics10111357.Antibiotics (Basel). 2021.PMID:34827295Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical